Turmeric has many benefits. One of them is that it can work as anti-depression medicine. Robin Williams could have avoided suicide if he was given Turmeric as medicine. Cancer is a cell level depression and identity crisis. Turmeric is emerging as best alternative medicine for cancer treatment.
Curcumin oil in Turmeric can do wonder. What you get from market is devoid of curcumin. It is first extracted and then powder is packaged for selling. So turmeric you use in kitchen may not work as per expectations. For curcumin rich turmeric, you will have to sacrifice your leisure time, travel across villages, meet farmers and find best source. I can help.
It is also not good idea to consume extracted curcumin (as modern pharma is planning to sell soon ) alone as magic is in whole turmeric and not in isolated curcumin.
So when you get time from your delusion that modern science is superior, start following your local food habits and avail benefits of healthy living.
Read this abstract as proof: http://onlinelibrary.wiley.com/doi/10.1002/ptr.5025/abstract
Efficacy and Safety of Curcumin in Major Depressive Disorder: A Randomized Controlled Trial
Curcumin, an active ingredient of Curcuma longa Linn (Zingiberaceae), has shown potential antidepressant-like activity in animal studies. The objectives of this trial were to compare the efficacy and safety of curcumin with fluoxetine in patients with major depressive disorder (MDD). Herein, 60 patients diagnosed with MDD were randomized in a 1:1:1 ratio for six weeks observer-masked treatment with fluoxetine (20 mg) and curcumin (1000 mg) individually or their combination. The primary efficacy variable was response rates according to Hamilton Depression Rating Scale, 17-item version (HAM-D17). The secondary efficacy variable was the mean change in HAM-D17 score after six weeks. We observed that curcumin was well tolerated by all the patients. The proportion of responders as measured by the HAM-D17 scale was higher in the combination group (77.8%) than in the fluoxetine (64.7%) and the curcumin (62.5%) groups; however, these data were not statistically significant (P = 0.58). Interestingly, the mean change in HAM-D17 score at the end of six weeks was comparable in all three groups (P = 0.77). This study provides first clinical evidence that curcumin may be used as an effective and safe modality for treatment in patients with MDD without concurrent suicidal ideation or other psychotic disorders. Copyright © 2013 John Wiley & Sons, Ltd.
